Presentation ACC 2024 Bridge-TIMI 73a: Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk Presenter: Brian Bergmark April 07, 2024 REGISTER for free or LOG IN to view this content Lipids Coronary Presentation ACC 2024 Up Next Presentation ACC 2024 Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial Presenter: Alexander Fanaroff April 07, 2024 More slides + Presentation ACC 2024 Acoramidis May Improve Cardiac Function and Promote Regression in Transthyretin Amyloid Cardiomyopathy: Data From the ATTRibute-CM Cardiac Magnetic Resonance Substudy Presenter: Yousuf Razvi April 06, 2024 Presentation ACC 2024 A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy Presenter: James L. Januzzi Jr April 08, 2024 We Recommend
Presentation ACC 2024 Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial Presenter: Alexander Fanaroff April 07, 2024
Presentation ACC 2024 Acoramidis May Improve Cardiac Function and Promote Regression in Transthyretin Amyloid Cardiomyopathy: Data From the ATTRibute-CM Cardiac Magnetic Resonance Substudy Presenter: Yousuf Razvi April 06, 2024
Presentation ACC 2024 A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy Presenter: James L. Januzzi Jr April 08, 2024